Prophase Labs Inc (PRPH) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access PRPH Annual Cash Flow →
Quarterly cash flow trends provide additional context on Prophase Labs Inc's liquidity and ability to support ongoing operations and capital needs.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
6 Months
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-8.23
Depreciation & amortization3.17
Amortization of Other Assets1.84
Increase (Decrease) in Deferred Revenue-0.36
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.01
Share-based Compensation1.14
Income (Loss) from Equity Method Investments-0.27
Financial Instruments and Foreign Currency Transaction0.12
Sales Discounts And Provision For Bad Debts-
Inventory Valuation Provision-
Settlement Benefit-
Income Tax Expense Benefit-
Increase Decrease In Assets Held For Sale Discontinued Operations-
Increase Decrease In Accrued Marketing Costs-
Loss On Sale Of Property Plant Equipment-
Increase Decrease In Escrow Receivable-
Marketable Securities Realized Gain Loss-
Operating Lease Right Of Use Asset Amortization Expense0.23
Lower Of Cost Or Net Realizable Value Inventory Adjustment-
Change In Fair Value Of Investment Securities-
Inventory Valuation Reserve-
Increase Decrease In Accrued Diagnostic Services-0.01
Increase Decrease In Deferred Income Tax Liabilities-
Increase Decrease In Operating Lease Liability-0.15
Debt Securities Available For Sale Realized Gain Loss0.62
Gain Loss On Issuance Of Debt-
Gain Loss On Termination Of Lease-
Noncash Employee Retention Tax Credit Income-
Income taxes0.00
Gain (Loss) on Sale of Properties0.27
Increase (Decrease) in Accounts Receivable0.01
Increase (Decrease) in Accounts Payable and Accrued Liabilities2.74
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.20
Other Working Capital0.07
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-1.13
Discontinued operations0.00
Net Cash flow from Operating Activities-0.83
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.01
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Proceeds From Maturities Of Marketable Securities-
Issuance Of Secured Promissory Note Receivable-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.01
Financing Activities
Short-term debt Net0.49
Other borrowing transactions0.00
Long-term debt - borrowings0.39
Long-term debt - repayments-0.18
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.04
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payment Of Dividends-
Proceeds From Exercise Of Warrants And Stock Options-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations0.68
Proceeds From Issuance Of Common Stock And Warrants From Private Offering-
Restricted Stock Value Shares Issued Net Of Tax Withholdings-
Repurchase Of Common Stock For Payment Of Statutory Taxes Due On Cashless Exercise Of Stock Option-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Proceeds From Issuance Of Public Offering-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.74
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.81
Total Cash Flow-0.07
4 historic quarters locked

Sign in to unlock the full Prophase Labs Inc cash flow history.

About Prophase Labs Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 19, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-039224

Figures are derived from filed reports and may be restated. Historical data is subject to revision.